Delivery Order SPE2DB25D3108-SPE2DB25FPDRC
Award Date 8/18/25
Potential Completion Date 8/19/25
Potential Value $6.7K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a delivery order valued at $1,993.43 to AmerisourceBergen Drug Corp for Mesalamine DR 400 mg capsules (180 count) on August 13, 2025, with an ultimate completion date of August 14, 2025. This competitively awarded, firm fixed-price delivery order represents a non-set-aside contract for pharmaceutical supply to support federal medical procurement needs. The product will be performed and delivered from AmerisourceBergen's corporate office located in...
- The Defense Logistics Agency awarded a delivery order valued at $1,286.99 to AmerisourceBergen Drug Corp for 120 tablets of Mesalamine DR 1.2 GM on August 15, 2025, with completion targeted for August 18, 2025. This firm fixed price delivery order represents a non-set-aside award issued under competitive procurement procedures. The product will be delivered to the contractor's corporate office location in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its headquarters as a major...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,284.56 fixed-price delivery order is for the supply of 180 capsules of 400 mg Mesalamine, a medication used to treat ulcerative colitis and other gastrointestinal conditions. The contract has an ultimate completion date of March 19, 2025 and is not designated with any set-aside requirements, indicating open...
- The Defense Logistics Agency awarded a $17,412.86 delivery order to AmerisourceBergen Drug Corp for 180 tablets of Mesalamine 800 mg delayed-release medication, with an ultimate completion date of July 29, 2025. This is a firm fixed-price, competitively awarded contract with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement, particularly...
- The Defense Logistics Agency awarded a delivery order valued at $3,334.85 to AmerisourceBergen Drug Corp for the supply of Mesalamine DR 1.2 GM tablets (120-count units) on July 23, 2025, with an ultimate completion date of July 24, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and is performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. The delivery order falls under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with...
- The Defense Logistics Agency awarded a $7,361.02 delivery order to AmerisourceBergen Drug Corp on July 29, 2025, for the supply of Mesalamine 400 mg capsules (180-count units). This non-set-aside contract features firm fixed pricing and is scheduled for completion by July 30, 2025, with performance taking place at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a discrete purchase under AmerisourceBergen's broader federal...
- The Defense Logistics Agency awarded a delivery order valued at $16,681.52 to AmerisourceBergen Drug Corp for the supply of Mesalamine 800 mg delayed-release tablets (180-count units). This firm fixed-price delivery order, issued on August 1, 2025, represents a non-set-aside competitive award with an ultimate completion date of August 4, 2025. The work will be performed at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania, where the company serves as a major pharmaceutical...
- The Defense Logistics Agency awarded a $2,113.94 delivery order to AmerisourceBergen Drug Corp for the supply of Mesalamine DR 1.2 GM tablets (120 count) on July 22, 2025, with an ultimate completion date of July 23, 2025. This competitively awarded, firm fixed-price contract involves no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen Drug Corp's larger Indefinite...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,143.47 firm-fixed-price contract is for the delivery of 180 units of 800 mg delayed-release mesalamine tablets, a medication used to treat gastrointestinal conditions. The contract has an ultimate completion date of October 20, 2022. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 30, 2025, for the supply of Mesalamine DR 1.2 GM tablets (120 count) with a ceiling value of $1,914.97. This is a firm fixed price delivery order with no set-aside designation, indicating competitive award to this qualified pharmaceutical distributor. The order is set to be completed by July 31, 2025, with performance occurring at AmerisourceBergen's corporate office location in Conshohocken,...